Get the Stockscreener App
2.38
3.48%
0.08
Processa Pharmaceuticals Inc stock is traded at $2.38, with a volume of 1,636.
It is up +3.48% in the last 24 hours and up +6.73% over the past month.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
See More
Previous Close:
$2.30
Open:
$2.29
24h Volume:
1,636
Relative Volume:
0.01
Market Cap:
$6.33M
Revenue:
-
Net Income/Loss:
$-13.56M
P/E Ratio:
-0.2447
EPS:
-9.7281
Net Cash Flow:
$-12.24M
1W Performance:
+2.15%
1M Performance:
+6.73%
6M Performance:
-55.30%
1Y Performance:
-75.69%
1-Day Range:
$2.28
$2.3801
1-Week Range:
$2.08
$2.50
52-Week Range:
$1.76
$19.63
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Name
Processa Pharmaceuticals Inc
Sector
Industry
Phone
443-776-3133
Address
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
2.3801 | 6.12M | 0 | -13.56M | -12.24M | -9.7281 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-24 | Initiated | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Stock (PCSA) Latest News
Trading Recap: Does Processa Pharmaceuticals Inc have a sustainable dividend2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Earnings Recap: Does Processa Pharmaceuticals Inc have strong fundamentalsRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in Processa Pharmaceuticals Inc (PCSA) - Stock Titan
Processa Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings - marketscreener.com
Aug Macro: Can Processa Pharmaceuticals Inc maintain sales growthMarket Growth Summary & Daily Price Action Insights - baoquankhu1.vn
Processa Pharmaceuticals Inc: Fundamental Analysis and Financial Ratings - marketscreener.com
Analyst Calls: What are the risks of holding Processa Pharmaceuticals Inc2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Processa Pharmaceuticals 2025 Annual Report: Next Generation Cancer Therapies, Regulatory Strategy, Pipeline, and Intellectual Property Overview - Minichart
Processa Pharmaceuticals 2025 10-K: $0 revenue, $(10.36) EPS on $(13.56)M net loss - TradingView
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[10-K] Processa Pharmaceuticals, I... - Stock Titan
Processa Pharmaceuticals Inc expected to post a loss of $1.50 a shareEarnings Preview - TradingView
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Gardner News
Growth Recap: Whats Processa Pharmaceuticals Incs historical return2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
EV Market: Can Processa Pharmaceuticals Inc maintain sales growthPortfolio Performance Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Aug Summary: Does Processa Pharmaceuticals Inc have a sustainable dividendWeekly Market Report & Entry Point Strategy Guides - baoquankhu1.vn
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Can Processa Pharmaceuticals Inc maintain sales growthJuly 2025 Trends & Weekly Top Performers Watchlists - baoquankhu1.vn
Processa Pharmaceuticals Stock Quote, Share Price, News and Analysis - Longbridge
Aug Setups: Will Vishay Intertechnology Inc benefit from current market trends2025 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Death Cross: What is Processa Pharmaceuticals Incs valuation compared to sectorRate Hike & Weekly Top Performers Watchlists - baoquankhu1.vn
PCSA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PCSA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PCSA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Chiliz Group boosts Processa (PCSA) stake to 13% with added share buy - Stock Titan
Smart Money: Should I hold or sell Processa Pharmaceuticals Inc nowGlobal Markets & Daily Profit Focused Stock Screening - baoquankhu1.vn
Will Processa Pharmaceuticals Inc. benefit from green energy policiesJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
Processa Ends PCS12852 Licensing Pact With Intact Therapeutics - TipRanks
Processa Pharmaceuticals (PCSA) term sheet for PCS12852 expires without final license - Stock Titan
Will Processa Pharmaceuticals Inc. benefit from seasonalityJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - mfd.ru
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Breakout Move: What is Processa Pharmaceuticals Incs valuation compared to sectorQuarterly Market Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Will Processa Pharmaceuticals Inc. outperform small cap indexesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - mfd.ru
Does Processa Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
What’s Processa Pharmaceuticals Inc.’s historical returnQuarterly Profit Review & Momentum Based Trading Ideas - mfd.ru
Institution Moves: Is Processa Pharmaceuticals Inc impacted by rising ratesEarnings Growth Summary & Consistent Profit Alerts - baoquankhu1.vn
Intracoastal Capital discloses 8.1% Processa (PCSA) ownership stake - Stock Titan
Aug Technicals: Does Processa Pharmaceuticals Inc have a sustainable dividendJuly 2025 Volume & High Accuracy Investment Entry Signals - baoquankhu1.vn
Should I hold or sell Processa Pharmaceuticals Inc. nowQuarterly Portfolio Report & Accurate Entry/Exit Alerts - mfd.ru
Does Processa Pharmaceuticals Inc. have a sustainable dividendQuarterly Earnings Report & Long-Term Safe Investment Plans - mfd.ru
Is Processa Pharmaceuticals Inc likely to announce a buybackGlobal Markets & Advanced Technical Analysis Signals - baoquankhu1.vn
Fed Meeting: Should I hold or sell Processa Pharmaceuticals Inc nowWeekly Market Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Jobs Data: What makes MNTK stock attractive todayJuly 2025 Sector Moves & Real-Time Market Trend Scan - baoquankhu1.vn
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Big Picture: Does Processa Pharmaceuticals Inc have a sustainable dividendInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Pharma Sector Update: Amneal Valuation, Processa Profile, and Balaxi Earnings - scoopsquare24.com
Big Money Moves: Can Processa Pharmaceuticals Inc maintain sales growth2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Patterns Watch: Does Processa Pharmaceuticals Inc align with a passive investing strategy - baoquankhu1.vn
Processa Pharmaceuticals Inc Stock (PCSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Processa Pharmaceuticals Inc Stock (PCSA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lin Patrick | Chief Business - Strategy Off |
Jan 01 '26 |
Option Exercise |
0.00 |
193 |
0 |
1,753 |
| Guy Wendy | Chief Administrative Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
193 |
0 |
1,256 |
| Bigora Sian | Chief Development Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
249 |
0 |
1,604 |
0.99%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):